Stéphane Bouchard reveals why BD's pharmaceutical systems centre of excellence is based in France; BD's increased strength in medical devices…

Massimo Visentin, Country Leader for Pfizer Italy, discusses the company’s remarkable success in 2015, his hopes and ambitions for the new year, and…

Bart van de Kerkhof highlights how Covidien’s acquisition will drive Medtronic to new heights thanks to a broader product portfolio. Medtronic is…

Dr. Giorgio Pisani, President and CEO of IBSA Italy, talks about his founding of the company in 2001 and its rapid growth in the market through a…

The CEO of Onxeo, recently formed through the merger of the French BioAlliance Pharma and the Danish Topotarget, discusses its strategic turning…

Alessandra Modenese Kauffmann, General Manager of the Swiss Chamber of Commerce, shares her insights into the relationship between Italy and…

Mr. Michel Finance, CEO of Theradiag, a leading French player in in vitro diagnostics and the novel field of theranostics (a combination of treatment…

After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies…

The CSO and COO of BioNovion talk about the company's recent acquisition by US-based biotech Aduro. BioNovion is a Dutch biopharma specialized in…

The President of Innothera talks about their unique business model, being in both the drug production and compression stockings businesses, how almost…

Muhammad Bodhania, Managing Director of Medreich South Africa discusses potential strategic implications of the recent acquisition of Medreich by…

“A company active in the Chilean pharmaceutical market has to reinvent its business model every three years because today we are competing against…